Our free tuberculosis information guide walks through the fundamentals of TB—what it is, how it spreads, and why understanding it matters for your health and the health of people around you. Rather than medical advice, this guide presents factual information about a disease that still affects millions of people worldwide and thousands in the United States each year.
Learn About Paying Your FGUA Bill Online →
Tuberculosis is caused by bacteria called Mycobacterium tuberculosis. According to the CDC, about 7,100 TB cases were reported in the United States in 2023, though this number has been declining over recent decades. Despite this progress, TB remains a serious public health concern, particularly in certain communities and among people with weakened immune systems.
The guide explains the two main forms of TB disease: active tuberculosis and latent TB infection. Active TB occurs when the bacteria multiply and cause symptoms like persistent cough, chest pain, and fatigue. Latent TB infection means someone carries the bacteria but shows no symptoms and cannot spread the disease to others. Understanding this distinction is crucial because it affects how the disease is detected and managed.
You'll learn about risk factors that increase the chances of developing TB, including living in close contact with someone who has active TB, having HIV or other conditions that weaken the immune system, or living in areas where TB is more common. Healthcare workers, people who are homeless, and individuals with certain chronic diseases face higher risks.
Practical takeaway: Understanding TB basics—what it is, how it develops, and who faces higher risks—gives you a foundation for recognizing symptoms in yourself or others and understanding why testing and treatment matter.
Testing is how TB is identified, and our guide explains the different tests used and what they tell you. The most common screening test is the tuberculin skin test (TST), also called a Mantoux test. A healthcare worker injects a small amount of purified protein derivative (PPD) just under the skin on your forearm. You return 48 to 72 hours later, and the provider measures any raised bump at the injection site to determine your result.
Free Guide to Pay by Plate Illinois Billing →
The guide also covers interferon-gamma release assays (IGRAs), which are blood tests that measure how your immune system reacts to TB antigens. These tests are increasingly used because they're more specific for TB infection and don't require a follow-up visit. Common IGRAs include the QuantiFERON test. Some people get both types of tests, or a healthcare provider might choose one over the other based on individual circumstances.
For people with a positive screening test, further testing confirms whether someone has latent TB infection or active TB disease. This usually involves a chest X-ray, which can show signs of active TB in the lungs. If the X-ray shows potential TB disease, sputum samples (mucus coughed up from the lungs) are tested using acid-fast bacilli (AFB) smear microscopy or TB culture tests. These tests directly identify the TB bacteria and help determine treatment options.
Drug susceptibility testing is another important part of diagnosis when active TB is suspected. This test shows whether the TB bacteria respond to standard TB medications or if the infection involves drug-resistant strains. Drug-resistant TB requires different treatment approaches and is more challenging to treat, making this test results critical for planning care.
The guide also touches on newer molecular tests that can rapidly identify TB and some forms of drug resistance. The Xpert MTB/RIF test, for example, can detect TB and rifampicin resistance within about two hours, which helps people start treatment faster.
Practical takeaway: Knowing which tests exist and what they show helps you understand what a provider might recommend, why follow-up tests matter, and what different results actually mean about TB status.
Active TB typically develops in the lungs, but it can affect other parts of the body. The guide details the main warning signs so you recognize when professional medical evaluation is needed. The most common symptom is a cough that lasts three weeks or longer. This isn't an ordinary cough—it tends to be persistent and may worsen over time.
Free Guide to Mold Removal Methods for Walls →
Other symptoms of active TB include chest pain, especially when breathing or coughing; coughing up blood or blood-tinged sputum; and shortness of breath. Beyond respiratory symptoms, people with active TB often experience fatigue, weight loss, chills, and fever that tends to be worse in the afternoon or evening. Night sweats, sometimes severe enough to soak through bedding, are another characteristic symptom.
Extrapulmonary TB—TB affecting areas outside the lungs—produces different symptoms depending on where the infection is. TB of the spine causes back pain. TB of the lymph nodes causes swollen glands, often in the neck. TB of the kidneys or urinary tract causes pain during urination. Meningitis-like symptoms, including severe headache and neck stiffness, can indicate TB meningitis, a serious form requiring immediate evaluation.
The guide emphasizes that a three-week or longer cough in any person warrants medical evaluation. This is not because every persistent cough is TB—many conditions cause prolonged cough—but because early identification of TB leads to faster treatment and prevents transmission to others. The risk of spreading TB increases the longer an untreated active case goes on. People with active TB become much less contagious within two weeks of starting appropriate treatment.
The guide also addresses how TB symptoms develop gradually. Unlike some infections that cause sudden, severe illness, TB often builds slowly. Someone might feel increasingly tired, lose appetite, or experience night sweats for weeks before recognizing a pattern worth mentioning to a healthcare provider.
Practical takeaway: Knowing the signs of active TB—especially a persistent cough lasting three weeks or more, chest pain with coughing, and unexplained weight loss or fatigue—helps you recognize when medical evaluation is appropriate for yourself or someone close to you.
Our guide explains the fundamentals of TB treatment, which relies on antibiotics to kill or stop the growth of TB bacteria. Standard treatment for drug-susceptible active TB involves a combination of four medications taken together for an initial phase, typically lasting two months. These medications are isoniazid, rifampicin, pyrazinamide, and ethambutol. After this intensive phase, treatment usually continues with isoniazid and rifampicin for four additional months.
How to Delete Your Fitbit Account Guide →
Why use multiple drugs at once? The guide explains that TB bacteria can develop resistance to a single drug if exposed to that drug alone. Using four different medications with different mechanisms of action prevents resistance from emerging. This is why completing the full course of treatment exactly as prescribed matters so much—stopping early or taking doses inconsistently can allow resistant bacteria to develop.
Treatment completion typically takes six months for drug-susceptible TB. This might seem like a long time, but it's the proven duration for curing most TB cases. The guide notes that people usually start feeling better within two to three weeks of starting treatment, which sometimes leads to the mistaken belief that treatment can be stopped early. However, the full course is necessary to eliminate all the bacteria and prevent relapse or drug resistance.
For latent TB infection, treatment is different and shorter. People with latent TB who are at high risk of developing active disease may be offered preventive therapy, which might be a single medication like isoniazid taken for six to nine months, or shorter regimens using combinations like rifampicin and isoniazid. Preventive therapy reduces the risk of developing active TB disease.
Drug-resistant TB requires longer treatment—sometimes 18 to 20 months or more—and uses different medications that have more side effects. Multi-drug-resistant TB (MDR-TB) is resistant to at least isoniazid and rifampicin. Extensively drug-resistant TB (XDR-TB) is resistant to even more drugs and is particularly serious. Newer medications are being used to treat drug-resistant forms, but these treatments are more complex and challenging.
The guide covers common side effects of TB medications, which might include nausea, liver problems, vision changes, or rashes. Most side effects are manageable, and the healthcare team can adjust treatment or add additional medications if side effects occur. Regular monitoring through blood tests and clinic visits helps catch problems early.
Practical takeaway: TB treatment works, but it requires taking multiple medications
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.